Acquired Immunodeficiency Syndrome: all 3,037 studies

Page 17 of 31. Open to participants first (307), then studies with results posted, then the rest; newest registration first within each.

• Absolute Bioavailability of BMS-626529 After Oral and Intravenous DosingCompletedNCT02805556Phase 1
• Factors Associated With Late HIV Diagnosis in Grampian: an Epidemiological StudyCompletedNCT02804724
• A Study to Evaluate the Effect of High Fat Meal on CabotegravirCompletedNCT02799264Phase 1
• Impact of ART Adherence on HIV Persistence and InflammationCompletedNCT02797093
• BRIDGE: Improving HIV Service Delivery for People Who Inject DrugsCompletedNCT02796027Not applicable
• Single and Repeated Dose Escalation Study of GSK2838232CompletedNCT02795754Phase 1
• Clinical Trial of Recombinant Adenovirus Type 5 AIDS VaccineStatus unknownNCT02762045Phase 1
• Adherence Connection for Counseling, Education, and SupportStatus unknownNCT02753049Not applicable
• Bioequivalence Study of a Fixed-dose Combination (FDC) of Dolutegravir (DTG) and Rilpivirine (RPV)CompletedNCT02741557Phase 1
• Relative Bio-availability Study of Dolutegravir and Lamivudine Fixed Dose CombinationsCompletedNCT02738931Phase 1
• Effect of Xpert MTB/RIF on Patient OutcomesCompletedNCT02729532
• A Study to Evaluate the Effect of BMS-955176 on Pharmacokinetics of Dolutegravir and the Effect of Dolutegravir on the Pharmacokinetics of BMS-955176CompletedNCT02715479Phase 1
• RH and AdolescentsCompletedNCT02713750
• Antiretroviral Regime for Viral Eradication in NewbornsCompletedNCT02712801Phase 4
• Pilot Trial of the Effect of Vorinostat and AGS-004 on Persistent HIV-1 InfectionTerminatedNCT02707900Phase 1
• Effectiveness of Nurse-delivered Care for Adherence/Mood in HIV in South AfricaCompletedNCT02696824Not applicable
• Addressing Psychosocial Comorbidities in HIV Treatment and PreventionCompletedNCT02696681Not applicable
• Cooperative Re-Engagement Controlled Trial (CoRECT)CompletedNCT02693145Not applicable
• Same-day ART Initiation Versus Standard of Care After Positive HIV-test Result in Rural LesothoCompletedNCT02692027Phase 3
• Safety, Tolerability and Immunogenicity Study of Different Vaccine Schedules With Ad26.Mos.HIV and Clade C Glycoprotein (gp)140 in Healthy Human Immunodeficiency Virus (HIV)-Uninfected AdultsCompletedNCT02685020Phase 1
• Dose Optimisation of Stavudine for the Treatment of HIV InfectionCompletedNCT02670772Phase 3
• Exploring the Impact of HIV and ART on Knowledge, Attitudes and Practices in Reproductive Health in Lilongwe, MalawiCompletedNCT02667808
• A Study to Assess the Effect of High Fat Meal and Increased Gastric pH on the Bioavailability of an Extended Release Formulation of BMS-663068 in Healthy SubjectsCompletedNCT02666053Phase 1
• A Study to Assess the Drug-drug Interaction of BMS 663068 With Methadone and Also With Buprenorphine/NaloxoneCompletedNCT02666001Phase 1
• HIV Drug Switch Followed by HCV Therapy in HIV-HCV Co-InfectionCompletedNCT02660905Phase 3
• Pomalidomide in Combination With Liposomal Doxorubicin in People With Advanced or Refractory Kaposi SarcomaActive, not recruitingNCT02659930Phase 1
• Triumeq As an Integrase Single Tablet Regimen in People With HIV Who Inject DrugsTerminatedNCT02659761Phase 4
• CC-11050 in Human Immunodeficiency Virus-1-Infected Adults With Suppressed Plasma Viremia on Antiretroviral Therapy (APHRODITE)CompletedNCT02652546Phase 1
• Safety and Efficacy of Allogenic Adoptive Immune Therapy for Advanced AIDS PatientsCompletedNCT02651376Phase 1/2
• Impact of Hepatitis C Virus Therapy on Central Nervous System OutcomesCompletedNCT02650024
• Safety and Efficacy of Allogenic Adoptive Immune Therapy for Immune Reconstitution in Chronic HIV-1 Infected PatientsStatus unknownNCT02648516Phase 1/2
• Depression Amongst HIV Positive Patients in LilongweCompletedNCT02646605
• Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S.CompletedNCT02641158Not applicable
• Community Intervention for HIV Testing & Care Linkage Among Young MSM in BulgariaCompletedNCT02639754Not applicable
• Feasibility of Measuring Immune Resp, Activation in Foreskin/Mucosa in HIV-, Uncircumcised High-HIV-risk MSM, Lima PeruCompletedNCT02630082Not applicable
• Motivation Matters StudyCompletedNCT02627365Not applicable
• Efficacy and Safety of TCA vs. ECA for the Treatment of AIN in HIV-positive PatientsCompletedNCT02615860Not applicable
• Effect of a Micro-finance-based Intervention for the Prevention of Intimate-partner Violence and HIVCompletedNCT02606344Not applicable
• Neural Correlates of Working Memory Training for HIV PatientsStatus unknownNCT02602418Not applicable
• Zambia SiVET MMR Tdap-IPVCompletedNCT02589678Phase 1/2
• The I-Score Study: Developing a New Patient-Reported Tool for the Routine HIV Care of Patients on Antiretroviral TherapyStatus unknownNCT02586584
• Bioequivalence Study of Two Formulations With the Association of Tenofovir 300 mg and Emtricitabine 200 mg.CompletedNCT02583464Phase 1
• Project BEST: Buprenorphine Entry Into Substance Abuse TreatmentCompletedNCT02583243
• Interventions to Improve HIV Care Engagement After Hospital DischargeCompletedNCT02578654Not applicable
• A Bioequivalence Study of Darunavir, Emtricitabine, and Tenofovir Alafenamide, in the Presence of Cobicistat in Healthy ParticipantsCompletedNCT02578550Phase 1
• A Study to Determine the Effect of Multiple Doses of BMS-955176 on the Electrocardiograph of Healthy SubjectsTerminatedNCT02576119Phase 1
• Antiviral Pharmacology and Adherence in Drug UsersCompletedNCT02573376Not applicable
• A Pilot Study of MONOtherapy of DOlutegravir in HIV-1 Virologically Suppressed PatientsCompletedNCT02572947Phase 2
• A Sleep Program to Improve Sleep Quality in People With HIVTerminatedNCT02571595Not applicable
• Cognitive Training for the Remediation of Functional Brain Health in HIVCompletedNCT02571504Not applicable
• The Georgia Latino AIDS/HIV Diagnosis and Linkage in Youth (GLADLY) ProjectTerminatedNCT02562092Not applicable
• Being Responsible for Ourselves HIV Risk Reduction for Black MSMCompletedNCT02561286Not applicable
• A Study to Evaluate the Pharmacokinetic Effects of Different Storage Conditions for a Long-Acting Nanosuspension of Rilpivirine on PharmacokineticsCompletedNCT02547870Phase 1
• Prospective Evaluation of HIV Patients Using Non-invasive Methods for Estimation of Liver Fibrosis and SteatosisStatus unknownNCT02542020
• Pharmacokinetics, Safety and Tolerability Study of Abacavir/ Dolutegravir/ Lamivudine Fixed-dose Combination Tablets in Healthy Japanese SubjectsCompletedNCT02539576Phase 1
• Evaluating Accuracy, Impact, and Operational Challenges of GeneXpert Use for TB Case Finding Among HIV-infected PersonsCompletedNCT02538952Phase 4
• Omega-3 Supplementation in HIV Patients With Therapeutic Lifestyle Change Diet.CompletedNCT02537236Phase 3
• Acceptance and Compassion to Enhance Self-care PilotCompletedNCT02535455Not applicable
• Impact of Hyperbilirubinemia Among HIV Patients Treated With AtazanavirCompletedNCT02532673
• Platelets Study: Influence of the Antiretroviral Treatment on the Platelet Physiology During HIV InfectionCompletedNCT02532348
• Energy Expenditure of People Living With HIV/AIDSCompletedNCT02530827
• Impact of Pre-ART Blood CD4+ T Cell Level on the Rectal Reservoir in Long-term HIV-1 Treated MenCompletedNCT02526940
• A Non-inferiority Randomized Controlled Trial to Evaluate Promoting Condom Use Among MSM and Transgender Individuals in ChinaCompletedNCT02516930Not applicable
• Friends for Life Circles for Option B PlusCompletedNCT02515370Not applicable
• Outcomes of HIV Infected Individuals After Ten Years on Antiretroviral TreatmentStatus unknownNCT02514707
• SMS as an Incentive To Adhere (SITA) - An Intervention Communicating Social Norms by SMS to Improve ARV AdherenceCompletedNCT02514356Not applicable
• Status of Chronic Liver Disease in Hepatitis C Virus (HCV) Patients Coinfected With Human Immunodeficiency Virus (HIV) in AndalusiaStatus unknownNCT02511496
• Bioavailability of BMS-626529 in Healthy Subjects From Prototype Low Dose Extended Release Formulations (Part 1) and Prototype Extended Release Multi-particulate Formulations (Part 2) of BMS-663068 Relative to 600 mg Extended Release TabletCompletedNCT02508064Phase 1
• The HPV-SAVE Study Team: HPV Screening and Vaccine Evaluation in Men Who Have Sex With MenTerminatedNCT02503111Not applicable
• Reducing Alcohol Dependence Among HIV-Positive IndividualsCompletedNCT02501057Not applicable
• Safety Study of Zinc Finger Nuclease CCR5-modified Hematopoietic Stem/Progenitor Cells in HIV-1 Infected PatientsActive, not recruitingNCT02500849Phase 1
• Darunavir/Cobicistat and Dolutegravir to Maintain Virologic Suppression and Reduce NRTI-associated ToxicityWithdrawnNCT02499978Phase 2/3
• Evaluating Demand Creation Strategies for Voluntary Medical Male Circumcision (VMMC) in KenyaCompletedNCT02497989Not applicable
• Community-Based Peer Facilitator Intervention (Zimbabwe)CompletedNCT02496793Not applicable
• A Roll-over Study With Rilpivirine for Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants Who Participated in Rilpivirine Pediatric StudiesCompletedNCT02494986Phase 2
• Demand Creation for Couples' HIV Counseling and TestingStatus unknownNCT02492061Not applicable
• Mother and Infant Visit Adherence and Treatment Engagement StudyCompletedNCT02491177Not applicable
• Study in Healthy Volunteers to Investigate the Safety, Tolerability and Pharmacokinetics of VM-1500CompletedNCT02489487Phase 1
• Clinical Trial of Safety and Pharmacokinetics of VM-1500 After Multiple Oral Administration in Healthy VolunteersCompletedNCT02489435Phase 1
• Assessment of Dolutegravir Removed by Hemodialysis in HIV-infected Patients With End-stage Renal DiseaseCompletedNCT02487706Phase 4
• Dual Therapy With Boosted Darunavir + DolutegravirCompletedNCT02486133Phase 3
• CPAP Improving Mortality for Pneumonia in African Children TrialTerminatedNCT02484183Not applicable
• Randomized Controlled Trial of Shang Ring Male Children Circumcision: Comparison Between Flip and No Flip TechniqueCompletedNCT02481492Not applicable
• A Open-label, Drug-Drug Interaction With Maraviroc (DDI)CompletedNCT02480894Phase 1
• A Drug-drug Interaction Study Between BMS-663068 and Oral Contraceptives in Healthy Female Volunteers (DDI)CompletedNCT02480881Phase 1
• Relative Bioavailability and Food Effect for Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Fixed Dose CombinationCompletedNCT02475135Phase 1
• Demonstration Project of PrEP Among Female Sex Workers in Dakar, SenegalCompletedNCT02474303Not applicable
• Single-dose Pharmacokinetics of BMS-626529, Administered as BMS-663068, in Subjects With Hepatic Impairment Compared to Healthy SubjectsCompletedNCT02467335Phase 1
• Improving Adherence Among HIV+ Rwandan Youth: A TI-CBTe Indigenous Leader ModelCompletedNCT02464423Not applicable
• Safety and Acceptability of Cabotegravir in HIV Uninfected Women in KwaZulu-Natal, South AfricaWithdrawnNCT02462772Phase 2
• Clinical Evaluation of the Xpert® HIV-1 VLCompletedNCT02461576
• ART Readiness in HIV-infected Pregnant WomenCompletedNCT02459678Not applicable
• The Safety and Immunogenicity of the DNA-GTU Vaccine Administered to HIV-infected Patients on ART vs PlaceboCompletedNCT02457689Phase 1/2
• Regular HIV Testing Among At-Risk Latino MenCompletedNCT02454725Not applicable
• Pilot Study of Oral Probiotic Bacteria Supplementation to Reduce Chronic Immune Activation in HIV-infected Malian WomenCompletedNCT02448238Not applicable
• Evaluation of the Texas Wellness Incentives and Navigation (WIN) ProjectCompletedNCT02440906Not applicable
• Effect of an Electronic Cognitive Aid Versus Static Cognitive Aid on the Management of a Simulated CrisisCompletedNCT02440607Not applicable
• Impact of RUTF on Body Composition, Anemia and Zinc Status of PLWHACompletedNCT02433743Not applicable
• Risk of CV Events With EFV vs. EFV-free RegimensCompletedNCT02426866
• Calcium and High-dose Vitamin D Supplementation on Bone Mineral Density Among HIV-infected Children and AdolescentsCompletedNCT02426840Phase 3

← Acquired Immunodeficiency Syndrome overview